Efficacy of Perioperative Opioid Sparing Techniques on Time to Initiation of Chemotherapy
Part of paid clinical trials in Knoxville, Tennessee.
- Sponsor
- University of Tennessee Graduate School of Medicine
- Study ID
- NCT07153614
- Status
- Recruiting
Conditions
- Perioperative Opioid Sparing Techniques
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Intrathecal Morphine Block — PROCEDUREMorphine 150 mcg
- Bilateral Quadratus Lumborum Block — PROCEDURE30 mL of 0.25% bupivacaine and 4mg of dexamethasone
- Bilateral Transverse Abdominis Plane Block — PROCEDUREExparel-based solution mixed with 50mL of saline
Study Details
The primary purpose of this study is to determine if intrathecal morphine (ITM) administration is superior to quadratus lumborum block or surgeon administered transversus abdominis plane (TAP) blocks result in decreased time to initiation of chemotherapy following oncologic surgery. The secondary objectives of this study are to determine: * The difference between interventions in time to return of bowel function in days * The difference between interventions in incidence of opioid related adverse drug events (ORADEs) * The difference between interventions in cumulative and post-operative total morphine milligram equivalents * The difference between interventions in quality-of-life assessment tool and patient satisfaction (brief pain index short form BPI-sf9) * The difference between interventions in hospital length of stay in days * The difference between cumulative pain scores between interventions * The difference between short acting and long-acting bupivacaine in pain management and time to chemotherapy The hypothesis is that preoperative intrathecal morphine administration will significantly reduce the time to initiation of postoperative chemotherapy.
Key Dates
- Start date
- Feb 3, 2025
- Status verified
- Aug 2025
- Primary completion
- Feb 3, 2027
- Completion
- Feb 3, 2027
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ITM groupPatients will receive an intrathecal morphine block performed by the Anesthesiologist. This will be accomplished by placing the patient in a preoperative holding room with standard ASA monitors 150 mcg of morphine will be administered intrathecally
- Active Comparator: QL groupPatients will receive a bilateral quadratus lumborum block containing 30 mL of 0.25% bupivacaine and 4mg of dexamethasone. This will be accomplished by placing the patient in a preoperative holding room with standard ASA monitors where the bilateral quadratus lumborum block will be performed by the Anesthesiologist
- Active Comparator: TAP block groupPatients will undergo a bilateral transverse abdominis plane block performed by the surgical team using an exparel-based solution mixed with 50mL of saline. This block will be performed intraoperatively before the incisions are closed
Primary Outcome Measure
Time to initiation of chemotherapy (in days) as deemed by a blinded medical oncologist [ Time Frame: Day of surgery to first chemotherapy session, assessed on (Day 30, Day 60, Day 90 visits) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Tennessee Graduate School of Medicine | Knoxville | Tennessee | 37920 | Che A. Solla MD, MBA (PRINCIPAL_INVESTIGATOR) |